1. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days;Group, I.S.A.M.Study,1986
2. A prospective placebocontrolled double-blind multicenter trial of intravenous streptokinase in acute mvocardial infarction (ISAM): long-term mortality and morbidity. j7Am Coll;Schroder, R.; Neuhaus, K.L.; Leizorovicz, A.;Cardiol,1987
3. The Western Washington intravenous streptokinase in acute myocardial ittfarction randomized trial;Kennedy, J.W.; Martin, G.V.; Davis, K.B.;Circulation,1988
4. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction;White, H.D.; Norris, RM\,; Brown, M.I.A.;N EnglJ Med,1987
5. A randomized controlled trial of intravenous streptokinase in acute myocardial intarction;Olson, H.G.; Butman, S.M.; Pitcrs, K.M.;Am Heart J,1986